Document is current
Any future updates will be listed below
-
Authors
Thorlacius, Linnea https://orcid.org/0000-0002-3734-9607
Riis, Peter T.
List, Emil Knudsen
Christensen, Robin
Jemec, Gregor B. E.
-
Funding
Funding for this research was provided by:
Oak Foundation (OCAY-18-774-OFIL)
Sjællands Universitetshospital
- License Information
-
More Information
Article History
Received: 28 April 2020
Revised: 13 August 2020
Accepted: 9 October 2020
First Online: 21 October 2020
Compliance with ethical standards
:
: LT has received speaker honoraria from UCB, had travel expenses covered by Abbvie and Janssen and been an investigator for Regeneron. GBEJ has received honoraria from AbbVie, Chemocentryx, Coloplast, Incyte, Inflarx, Novartis, Pierre Fabre and UCB for participation on advisory boards, and grants from Abbvie, Astra-Zeneca, Inflarx, Janssen-Cilag, Leo Pharma, Novartis, Regeneron and Sanofi, for participation as an investigator, and received speaker honoraria from AbbVie, Boehringer-Ingelheim, Galderma, MSD and Novartis. He has also received unrestricted departmental grants from Leo Pharma and Novartis. RC, PTR and EKL declare no conflicts of interest.
